207 related articles for article (PubMed ID: 8551911)
1. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
[No Abstract] [Full Text] [Related]
2. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
Pier GB
Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
[No Abstract] [Full Text] [Related]
3. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
Coin D; Vacheron MJ; Guinand M; Michel G
FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
[TBL] [Abstract][Full Text] [Related]
4. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
[TBL] [Abstract][Full Text] [Related]
5. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
[TBL] [Abstract][Full Text] [Related]
6. [Immunobiological properties of recombinant atoxic forms of the Pseudomonas aeruginosa exotoxin A].
Isakov MA; Soldatenkova AS; Kaloshin AA; Mikhaĭlova NA
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):37-42. PubMed ID: 21598613
[TBL] [Abstract][Full Text] [Related]
7. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
Homma JY; Tanimoto H
Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
[No Abstract] [Full Text] [Related]
8. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
[TBL] [Abstract][Full Text] [Related]
9. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
Klinger KW; Shuster CW; Klinger J
Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
Trancassini M; De Vito D; Quattrucci S; Cipriani P
New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606
[TBL] [Abstract][Full Text] [Related]
11. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A.
Rutault K; Vacheron MJ; Guinand M; Michel G
Infect Immun; 1993 Dec; 61(12):5417-20. PubMed ID: 8225617
[TBL] [Abstract][Full Text] [Related]
14. [Prevelance of antibodies ot OEP, exotoxin A, and exoenzymes of Pseudomonas aeruginosa in man (author's transl)].
Shinozaki T; Fujii R; Sanai Y; Homma JY
Kansenshogaku Zasshi; 1981 Jan; 55(1):32-40. PubMed ID: 6788869
[No Abstract] [Full Text] [Related]
15. [Serodiagnosis of Pseudomonas aeruginosa infections in mucoviscidosis: comparative study of Western blotting, ELISA exotoxin A and ELISA phospholipase C].
Fournier C; Andre J; Marlier H; Guinet R; Gilly R
Pathol Biol (Paris); 1993 Nov; 41(9):856-64. PubMed ID: 8121717
[TBL] [Abstract][Full Text] [Related]
16. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies.
Rutault K; Coin D; Vacheron MJ; Guinand M; Wallach J; Michel G
FEMS Microbiol Immunol; 1992 Jul; 4(5):267-72. PubMed ID: 1381199
[TBL] [Abstract][Full Text] [Related]
17. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
Homma JY; Tanimoto H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
[No Abstract] [Full Text] [Related]
18. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F
Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
[TBL] [Abstract][Full Text] [Related]
19. Host translational inhibition by Pseudomonas aeruginosa Exotoxin A Triggers an immune response in Caenorhabditis elegans.
McEwan DL; Kirienko NV; Ausubel FM
Cell Host Microbe; 2012 Apr; 11(4):364-74. PubMed ID: 22520464
[TBL] [Abstract][Full Text] [Related]
20. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
